Pharmaceuticals, Biotechnology and Life Sciences
WARREN, N.J.–(BUSINESS WIRE)–Tevogen Bio Holdings (‘Tevogen Bio’) (Nasdaq: TVGN), today announced TVGN 489, its investigational allogeneic SARS-CoV-2 specific Cytotoxic CD8+…
– The American Society of Regional Anesthesia and Pain Medicine is the largest subspecialty medical society in anesthesiology TORONTO–(BUSINESS WIRE)–$ATBPF–Antibe…
Furosemide represents the company’s fifth product launch and third product announced during DCAT Week 2024 SCHAUMBURG, Ill.–(BUSINESS WIRE)–Avenacy, a specialty…
FT. MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics, Inc. (NASDAQ: NEO), a leading oncology testing services company, today released its 2023 Environmental, Social, and…
Financing syndicate led by RA Capital Management includes new investors Forbion, Johnson & Johnson Innovation – JJDC, Mubadala Capital, Perceptive…
Opdivo plus Yervoy demonstrates statistically significant and clinically meaningful improvement in overall survival compared to investigator’s choice of sorafenib or…
Sustained efficacy 4 years after injection in REFLECT Phase III trial Continued benefit at 4 years in bilaterally treated patients:…
Full-Year 2023 Highlights: Revenues of $130.2 million, an increase of 47% over 2022 revenues of $88.6 million. GAAP net loss…
Conference Call and Webcast March 20 at 8:00 AM Eastern Time / 7:00 AM Central Time ReMEDy2 Clinical Site Activation…
Expanded clinical pipeline into autoimmune diseases with U.S. Food and Drug Administration (FDA) clearance of Investigational New Drug Application (IND)…